F.D.A. Requests Federal Investigation of Alzheim
Post# of 148184
F.D.A. Requests Federal Investigation of Alzheimer’s Drug Approval
The agency’s acting head said a review should look into whether any interactions between agency staff and the drug developer, Biogen, broke F.D.A. rules.
https://www.nytimes.com/2021/07/09/health/adu...ation.html